BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6132309)

  • 1. Bone scanning and early breast cancer: five-year follow-up.
    Roberts MM; Hayward JL
    Lancet; 1983 Apr; 1(8331):997-8. PubMed ID: 6132309
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial scintiscanning in breast cancer: the indications and prognostic value.
    Furnival CM; Blumgart LH; Citrin DL; McKillop JH; Fogelman I; Greig WR
    Clin Oncol; 1980 Mar; 6(1):25-32. PubMed ID: 7371234
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone scanning: its lack of value in the follow-up of patients with breast cancer.
    Bishop HM; Blamey RW; Morris AH; Rose DH; Preston B; Lane J; Doyle PJ
    Br J Surg; 1979 Oct; 66(10):752-4. PubMed ID: 509054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serial bone scanning in operable breast cancer.
    Monypenny IJ; Grieve RJ; Howell A; Morrison JM
    Br J Surg; 1984 Jun; 71(6):466-8. PubMed ID: 6722488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of bone scintigraphy screening in postoperative follow-up of breast cancer patients].
    Ohnari N; Shiozaki H; Ishino Y; Nakata H
    Gan No Rinsho; 1990 Dec; 36(15):2546-8. PubMed ID: 2266587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of preoperative bone scanning in breast cancer].
    Kitamura M; Tominaga T; Hayashi K; Takahashi I; Suzuki K
    Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1840-4. PubMed ID: 6672136
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
    Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 9. Late bone metastasis in breast carcinoma.
    Lopez-Majano V; Sobti P; Layon J
    Eur J Nucl Med; 1983; 8(5):227-9. PubMed ID: 6873098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of routine bone scintigraphy in primary operable breast cancer].
    Thomsen HS; Munck O; Andersen KW
    Ugeskr Laeger; 1984 Jun; 146(26):1915-8. PubMed ID: 6506284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone scintigraphy as a routine study in patients with breast cancer; a critical appraisal].
    Heslinga JM; Pauwels EK; Zwaveling A
    Ned Tijdschr Geneeskd; 1982 Jun; 126(23):1036-9. PubMed ID: 7110396
    [No Abstract]   [Full Text] [Related]  

  • 12. Retroperitoneal tumour infiltration detected by bone scanning in patients with infiltrating lobular carcinoma of the breast.
    Wilkinson MJ; Howell A; Harris M; Adam NM; Lupton E; Johnson RJ; Sellwood RA
    Br J Surg; 1985 Aug; 72(8):626-8. PubMed ID: 4027536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer].
    Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of follow-up bone scans in the management of postoperative breast cancer--when should it be performed?].
    Suzuki T; Watarai J; Ohgushi M; Adachi M; Yamaguchi K
    Gan No Rinsho; 1987 Sep; 33(11):1314-7. PubMed ID: 3669318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone metastases in breast cancer and its risk factor--follow up study by bone scintigraphy].
    Tanaka S; Matsumura Y; Tanaka M; Okamura T; Oda J; Ochi H; Onoyama Y; Morimoto K; Nakatani M; Fujimoto M
    Kaku Igaku; 1991 Oct; 28(10):1177-80. PubMed ID: 1800779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone scintiscanning in the diagnosis and follow-up of breast carcinoma].
    Arzano S; Curzi NM; Fatati G; Grimani A; Buzzi A; Giordano GP; Grignani F
    Quad Sclavo Diagn; 1980 Dec; 16(4):459-66. PubMed ID: 7244115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment bone scans in breast carcinoma.
    Graham DY
    AJR Am J Roentgenol; 1980 Jan; 134(1):210. PubMed ID: 6766029
    [No Abstract]   [Full Text] [Related]  

  • 18. Is skeletal scintigraphy indicated in all patients with breast cancer?
    Preece PE
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):64. PubMed ID: 2031884
    [No Abstract]   [Full Text] [Related]  

  • 19. [Routine scintigraphy of the skeleton in breast cancer in Sweden 1986-1987].
    Tejler G
    Lakartidningen; 1988 Mar; 85(10):846, 848. PubMed ID: 3352378
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition of metastatic bone disease in cancer of the breast by computed tomography.
    Durning P; Best JJ; Sellwood RA
    Clin Oncol; 1983 Dec; 9(4):343-6. PubMed ID: 6607147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.